Journal of Urologic Oncology

Prostate Cancer

Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials: Matthew Rashid, Eli Oldham, Griffin K. Hughes, Andriana M. Peña, Chase Ladd, Brooke Gardner, Ryan McIntire, Bradley Johnson, Jordan Tuia, Alyson Haslam, Vinay Prasad, Matt Vassar; Journal of Urologic Oncology. 2024;22(3):211-223. Published online November 30, 2024; DOI: https://doi.org/10.22465/juo.244800520026
Cited By 1; Full text PubReader ePub PDF

Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer

Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023: Jiwoong Yu, Hyun Hwan Sung; Journal of Urologic Oncology. 2023;21(3):228-240. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600420021
Cited By 2; Full text PubReader ePub PDF

Current Update on Prostate Cancer Immunotherapy: Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim; Journal of Urologic Oncology. 2023;21(1):14-22. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600100005; Full text PubReader ePub PDF

Subcutaneous Interleukin-2 Monotherapy for Metastatic Renal Cell Carcinoma in Korean Patients: Jeong Ho Kim, Ki Soo Lee, Choung-Soo Kim, Young Deuk Choi, Tae Hyo Kim; Korean J Urol Oncol. 2021;19(4):252-260. Published online November 25, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.4.252; Full text PubReader ePub PDF

6,292	Complex Epidemiology of Prostate Cancer in Asian Countries
4,173	Current Update on Prostate Cancer Immunotherapy
4,050	Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
3,845	Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
3,669	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades

Cited By 11	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 10	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 3	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By 3	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review

Search